Teva Pharmaceuticals CEO Richard Francis reflects on company performance in 2024, drug pricing, getting more drugs to market and supply shortages of the drug Adderall.
He speaks to Bloomberg's Katie Griefeld from the JPMorgan Healthcare Conference.

Estonia Prime Minister Kristen Michal Talks Support for Ukraine in EU
10:13

Blackstone President Jonathan Gray Talks AI Infrastructure
07:45

ServiceNow CEO Bill McDermott Talks Q1 Earnings
07:00